Testosterone and CRP blood tests

What testosterone and CRP each show

Testosterone and C-reactive protein (CRP) can be measured from the same blood draw. Testosterone is an androgen steroid hormone, produced mainly by the testes and in smaller amounts by the ovaries and adrenal glands. It is synthesized from cholesterol and circulates in the bloodstream. CRP is an acute-phase protein made by the liver in response to immune signals associated with inflammation.

The two results describe different processes. Testosterone contributes to sexual development and reproductive function, helps maintain muscle and bone, supports red blood cell production, and influences sexual desire. Symptoms such as changes in energy or mood can accompany hormone deficiency, but have many other causes. CRP rises in response to infections, tissue injury, and chronic inflammatory processes. Measuring both can provide information about androgen status and inflammation; it is not a combined score of overall health.

What considering them together can add

The pairing brings a hormone involved in tissue maintenance alongside an inflammation marker. That can be useful when a clinician has reason to investigate both, for example symptoms suggesting testosterone deficiency alongside a separate question about inflammation. It does not directly measure how well tissue is being repaired or how well someone recovers from training.

Researchers study links between testosterone, inflammation, muscle and bone health, fertility, mood, glucose and fat metabolism, cardiovascular disease, and frailty. These associations are interesting because illness, body composition, and hormone signaling can influence one another. But an association does not establish which change came first or show that raising testosterone will lower CRP or prevent disease.

Putting low and high values in context

Testosterone reference ranges vary with sex, age, and assay. Adult male levels are substantially higher than female levels. A diagnosis of hypogonadism in men needs compatible symptoms and consistently low testosterone, usually confirmed with a repeat morning fasting measurement. Neither one borderline result nor a position below the middle of the range establishes deficiency.

Low testosterone in men can reflect reduced testicular production, altered pituitary signaling, acute illness, certain medicines, or other factors. Symptoms may include reduced libido, loss of muscle, anemia, and lower bone density, but fatigue and low mood are not specific. In women, a low blood value alone does not diagnose low sexual desire or explain low energy. In adolescents, deficient androgen production can delay pubertal development and needs age-appropriate assessment.

High testosterone or androgen exposure can be associated with acne and oily skin. With testosterone treatment or nonmedical androgen use, a rise in red blood cells and suppression of sperm production are important concerns; these effects should not be attributed automatically to any naturally high-normal result. In women, elevated androgens can accompany irregular cycles, excess facial or body hair, and acne. Polycystic ovary syndrome is one possible explanation, not the only one.

Low CRP generally suggests little activity in the inflammatory processes it captures; it does not exclude every inflammatory condition. Elevated CRP can reflect acute illness or chronic inflammation. Persistently elevated high-sensitivity CRP (hs-CRP), measured in an appropriate setting, is associated with cardiovascular risk. It needs to be considered with the wider risk profile, not treated as a stand-alone diagnosis or a number to push as low as possible. Pregnancy can also affect CRP, while hormone interpretation differs by sex and developmental stage.

Other factors that change the measurements

Morning collection helps interpret testosterone in men with a usual sleep schedule. Total and free testosterone are different measurements. Accurate, validated total-testosterone assays matter; LC-MS/MS is especially useful at low concentrations. Where indicated, free testosterone may be assessed by equilibrium dialysis or calculated from appropriate measurements rather than assumed from the total alone.

Pregnancy and oral estrogens can raise sex hormone-binding globulin (SHBG). This changes the relationship between total and free testosterone: a higher binding-protein concentration does not simply mean greater androgen activity. SHBG also varies with other conditions, so its effects need to be interpreted in context. Oral estrogens can raise CRP as well.

Acute illness, strenuous exercise, smoking, and medicines can affect CRP. Illness can temporarily lower testosterone too. These influences help explain why repeating a result under suitable conditions may be more useful than immediately treating it as a lasting hormonal problem.

Testosterone, CRP, metabolism, and aging

The biological connection is worth studying. Testosterone helps maintain muscle, bone, red blood cell production, and sexual function. CRP marks inflammatory activity related to immune responses and, in some settings, metabolic and vascular risk. Neither result directly measures the speed of aging.

In men, low testosterone can accompany reduced testicular production or insufficient stimulation from the pituitary. Body composition, illness, medicines, and age also matter. High SHBG can lower the free fraction relative to total testosterone; it is not a general explanation for low total testosterone. Women’s physiological concentrations are much lower. A low CRP usually indicates little detectable systemic inflammatory activity, although genetics and severe liver dysfunction can complicate that interpretation.

Values within the appropriate reference range may be reassuring in context, but the middle is not a universal personal optimum. Symptoms, repeated measurements, and the reason for testing matter more than trying to optimize a paired testosterone–CRP score. Lower stable hs-CRP is associated with lower cardiovascular risk at the population level, without proving that changing this marker alone improves an individual’s outcome.

Higher testosterone may reflect external androgen use, particular hormone disorders, or changes in binding proteins. Low SHBG can increase the free fraction relative to total testosterone; it does not generally explain a high total value. CRP can rise with infection, tissue injury, chronic inflammatory disease, and obesity. A persistent finding is an invitation to investigate the relevant cause, rather than assume the two results share one explanation.

Frequently asked questions

What is a testosterone/CRP test?

It measures testosterone and C-reactive protein in blood. The results offer separate information about androgen status and inflammation. There is no standard combined value that measures recovery, resilience, or overall health.

Why would I have testosterone tested?

Testing can help investigate symptoms or signs of androgen deficiency or excess and monitor prescribed treatment. Energy, libido, body composition, and training history provide context, but a routine performance panel is not a substitute for a clinical reason to test. Repeat measurements may clarify whether a finding persists.

How often should testosterone and CRP be tested?

There is no general three-to-six-month schedule for everyone who trains or changes their lifestyle. Testing frequency follows the question, symptoms, and any treatment plan. Repeat testosterone measurements should use comparable timing and conditions; CRP follow-up depends on why it was elevated.

What can affect my testosterone level?

Sleep, energy intake, training load, stress, alcohol, weight changes, illness, and certain medicines can affect it. Their impact varies, and a temporary change is not automatically a hormone disorder.

How should I prepare for the blood draw?

For investigation of low testosterone in men, morning fasting samples are commonly used. Follow the clinic’s instructions and discuss shift work or unusual sleep times. Mention recent illness, unusually strenuous exercise, and heavy drinking. There is no single 24-hour rule that guarantees these influences have disappeared, and medicines should not be changed without instructions.

How is an unusual testosterone result investigated?

Symptoms, sleep, food intake, training, weight changes, and medicines all matter. A low result in a man generally needs repeat confirmation under suitable conditions. Depending on the findings, LH, FSH, SHBG, or a reliable free-testosterone assessment can help identify the pattern. CRP cannot replace this hormonal assessment.

Can lifestyle changes affect testosterone?

Yes. Adequate sleep and energy intake, appropriate exercise, and changes in body weight can influence levels and improve health. That does not guarantee a lasting testosterone rise or establish a treatment for a specific pituitary or testicular disorder. A persistent symptomatic abnormality deserves assessment alongside lifestyle measures.

Sources

• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229 Source

• Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet, 375(9709), 132-140. https://doi.org/10.1016/S0140-6736(09)61717-7 Source

• Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, Lapauw B, Fiers T, Matsumoto AM, Bhasin S (2017). Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. The Journal of Clinical Endocrinology and Metabolism, 102(4), 1161-1173. https://doi.org/10.1210/jc.2016-2935 Source

• Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT (2024). Polycystic ovary syndrome. Nature Reviews Disease Primers, 10(1), 27. https://doi.org/10.1038/s41572-024-00511-3 Source

• Gasbarrino K, Daly E, Daskalopoulou SS (2022). An LC-MS/MS methodological framework for steroid hormone measurement from human serum. Hormone and Metabolic Research, 54(5), 300-307. https://doi.org/10.1055/a-1768-0709 Source

• Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019). Full consensus statement.